Nu Skin Enterprises, Inc.
NUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.7% | 5.9% | -18.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 70.5% | 68.8% | 67.8% | 62.7% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 8.8% | 11.1% | 41.7% | -8% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 4.7% | 5.5% | 29.5% | -8.1% |
| EPS Diluted | 0.34 | 0.43 | 2.14 | -0.73 |
| % Growth | -20.9% | -79.9% | 393.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |